Innovative approaches to specifically target the melanoma subpopulation responsible for local invasion and metastatic dissemination are needed. Prominin-1 (CD133) expression has been observed in many melanoma cell lines, as well as in primary and metastatic melanomas from patients. Although its function(s) in melanoma is presently unknown, prominin-1 may represent a molecular target, due to its association with melanoma stem cells and with the metastatic phenotype. © 2013 Springer Science+Business Media New York.
CITATION STYLE
Lorico, A., Mercapide, J., & Rappa, G. (2013). Prominin-1 (CD133) and metastatic melanoma: Current knowledge and therapeutic perspectives. Advances in Experimental Medicine and Biology. Springer New York LLC. https://doi.org/10.1007/978-1-4614-5894-4_13
Mendeley helps you to discover research relevant for your work.